Cargando…

S101: COMBINATION OF A LUSPATERCEPT-LIKE DRUG (RAP-GRL) AND TMPRSS6-ASO IS SUPERIOR TO EITHER DRUG ALONE FOR CORRECTING β-THALASSEMIA

Detalles Bibliográficos
Autores principales:	Guerra, A., Demsko, P., Sinha, S., McVeigh, P., Castruccio Castracani, C., Breda, L., Casu, C., Rivella, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806388/ http://dx.doi.org/10.1097/HS9.0000000000000684

Ejemplares similares

P1520: AN ACTIVIN RECEPTOR IIB LIGAND TRAP, IN COMBINATION WITH TMPRSS6 INDUCED IRON-RESTRICTION, IS A SUPERIOR TREATMENT FOR CORRECTING Β-THALASSEMIA IN MICE
por: Guerra, A., et al.
Publicado: (2022)

Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice
por: Casu, Carla, et al.
Publicado: (2021)

Luspatercept‐induced reduction in transfusion requirement in α‐thalassemia
por: Jackson, Nicholas, et al.
Publicado: (2020)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

Efficacy and Safety of Luspatercept in the Treatment of β-Thalassemia: A Systematic Review
por: Dighriri, Ibrahim M, et al.
Publicado: (2022)

Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence
por: Longo, Filomena, et al.
Publicado: (2023)

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
por: Piga, Antonio, et al.
Publicado: (2022)

Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009)

P1506: REAL-WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA
por: Delaporta, P., et al.
Publicado: (2022)

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
por: Fu, Ziyang, et al.
Publicado: (2021)

GrlR, a negative regulator in enteropathogenic E. coli, also represses the expression of LEE virulence genes independently of its interaction with its cognate partner GrlA
por: Lara-Ochoa, Cristina, et al.
Publicado: (2023)

Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia
por: Chen, Nianhang, et al.
Publicado: (2020)

P1518: LONG-TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA-THALASSEMIA
por: Viprakasit, V., et al.
Publicado: (2022)

Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
por: Hatzimichael, Eleftheria, et al.
Publicado: (2022)

Role of Luspatercept in the Management of Lower-Risk Myelodysplastic Syndromes
por: Tinsley-Vance, Sara M., et al.
Publicado: (2023)

Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor
por: Hu, Guodong, et al.
Publicado: (2016)

Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England
por: Beynon, Caryl M, et al.
Publicado: (2006)

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
por: Komrokji, Rami S., et al.
Publicado: (2022)

P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
por: Coates, Thomas D., et al.
Publicado: (2023)

S102: OBLIGATE N-TERMINAL BUT NOT C-TERMINAL MONOFERRIC TRANSFERRIN AMELIORATES ANEMIA IN β-THALASSEMIC MICE
por: Guerra, A., et al.
Publicado: (2022)

GrlJ, a Dictyostelium GABA(B)-like receptor with roles in post-aggregation development
por: Prabhu, Yogikala, et al.
Publicado: (2007)

Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity
por: Marti, Amelia, et al.
Publicado: (2006)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Hattori, Shin-ichiro, et al.
Publicado: (2020)

Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy
por: Musallam, Khaled M, et al.
Publicado: (2023)

101 things you don't know about science and no one else does either
por: Trefil, James
Publicado: (1996)

The putative G protein–coupled receptor GrlD mediates extracellular polyphosphate sensing in Dictyostelium discoideum
por: Suess, Patrick M., et al.
Publicado: (2019)

TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
por: Ganz, Tomas, et al.
Publicado: (2023)

Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
por: Weidner, Heike, et al.
Publicado: (2022)

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
por: Komrokji, Rami S., et al.
Publicado: (2023)

MicroRNA-101 suppresses colorectal cancer progression by negative regulation of Rap1b
por: Zhou, Zhiyuan, et al.
Publicado: (2020)

Recent trends in the gene therapy of β-thalassemia
por: Finotti, Alessia, et al.
Publicado: (2015)

Structure of GrlR and the Implication of Its EDED Motif in Mediating the Regulation of Type III Secretion System in EHEC
por: Jobichen, Chacko, et al.
Publicado: (2007)

Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept
por: Delanghe, Sigurd, et al.
Publicado: (2022)

Detection of erythropoiesis stimulating agent Luspatercept after administration to healthy volunteers for antidoping purposes
por: Marchand, Alexandre, et al.
Publicado: (2022)

Patent and Marketing Exclusivities 101 for Drug Developers
por: Oronsky, Bryan, et al.
Publicado: (2023)

Either Rap1 or Cdc13 can protect telomeric single-stranded 3′ overhangs from degradation in vitro
por: Runnberg, Rikard, et al.
Publicado: (2019)

P1508: LUSPATERCEPT REDUCES THE BURDEN OF RED BLOOD CELL TRANSFUSION IN PATIENTS WITH BETA -THALASSEMIA AND COMORBIDITIES: THE EXPERIENCE OF A SINGLE THALASSEMIA AND SICKLE CELL UNIT IN A UNIVERSITY HOSPITAL
por: Delicou, S., et al.
Publicado: (2022)

An Autocrine Proliferation Repressor Regulates Dictyostelium discoideum Proliferation and Chemorepulsion Using the G Protein-Coupled Receptor GrlH
por: Tang, Yu, et al.
Publicado: (2018)

In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023)

Screening of Anti-Adhesion Agents for Pathogenic Escherichia coli O157:H7 by Targeting the GrlA Activator
por: Hong, Sin Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vv1nev9ltu570c12aqqg1rchdu